Outlook Therapeutics, Inc. Uncategorized Contracts & Agreements

38 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Syntone Inducement Letter
Outlook Therapeutics, Inc.
Biotechnology
DE
2025
Form of Inducement Letter
Outlook Therapeutics, Inc.
Biotechnology
DE
2025
Description of Registrant's securities
Outlook Therapeutics, Inc.
Biotechnology
2024
Form of Support Agreement
Outlook Therapeutics, Inc.
Biotechnology
DE
2024
Description of Registrants securities
Outlook Therapeutics, Inc.
Biotechnology
2023
At-the-market-sales agreement between the Company and BTIG, LLC dated May 16, 2023
Outlook Therapeutics, Inc.
Biotechnology
NY
2023
Description of Registrants securities
Outlook Therapeutics, Inc.
Biotechnology
2022
Letter Agreement, dated December 22, 2022, by and between the Company and M.S. Howells & Co
Outlook Therapeutics, Inc.
Biotechnology
NY
2022
At The Market Offering Agreement between the Company and H.C. Wainwright & Co. dated March 26, 2021
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Form of Underwriter Warrants
Outlook Therapeutics, Inc.
Biotechnology
2021
Description of Registrants securities
Outlook Therapeutics, Inc.
Biotechnology
2020
Engagement Letter, dated June 2, 2020, by and between the Company and H.C. Wainwright & Co., LLC
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Engagement letter dated December 10, 2019 by and between the Company and H.C. Wainwright & Co. LLC
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Global Amendment, dated as of January 29, 2020
Outlook Therapeutics, Inc.
Biotechnology
2020
Agreement to Amend Series A-1 Convertible Preferred between the Company and BioLexis Pte. Ltd., dated as of January 27, 2020
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Amendment dated March 4, 2019 of Strategic Partnership Agreement between the Registrant and MTTR LLC effective as of February 15, 2018, as amended
Outlook Therapeutics, Inc.
Biotechnology
2019
Amendment dated June 4, 2019 of Strategic Partnership Agreement between the Company and MTTR LLC effective as of February 15, 2018, as amended
Outlook Therapeutics, Inc.
Biotechnology
2019
Strategic Partnership Agreement by and between the Registrant and MTTR, LLC, effective as of February 15, 2018, as amended by the Letter Addendum dated March 2, 2018
Outlook Therapeutics, Inc.
Biotechnology
DE
2018
Lock-up Agreement by and among Oncobiologics, Inc., the Investor named therein and Pankaj Mohan, Ph.D., dated September 7, 2017
Outlook Therapeutics, Inc.
Biotechnology
NY
2017
securityagreement
Outlook Therapeutics, Inc.
Biotechnology
NY
2016
SECURITIES PURCHASEAGREEMENT
Outlook Therapeutics, Inc.
Biotechnology
DE
2016
ONCOBIOLOGICS, INC.
Outlook Therapeutics, Inc.
Biotechnology
2016
EXECUTIVEEmployment Agreement
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
EXECUTIVEEmployment Agreement
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
EXECUTIVEEmployment Agreement
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
EXECUTIVEEmployment Agreement
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
CONFIDENTIAL
Outlook Therapeutics, Inc.
Biotechnology
2016
L E AS E A G R E E M E N T
Outlook Therapeutics, Inc.
Biotechnology
2016
L E A S E A G R E E M E N T
Outlook Therapeutics, Inc.
Biotechnology
2016
JointParticipation Agreement ByAnd Between Oncobiologics,Inc. And ZhejiangHuahai Pharmaceutical Co., Ltd. Effectiveas of May 6 , 2013
Outlook Therapeutics, Inc.
Biotechnology
2016
CONFIDENTIAL
Outlook Therapeutics, Inc.
Biotechnology
2016
IndemnityAgreement
Outlook Therapeutics, Inc.
Biotechnology
DE
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
Biotechnology
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
Biotechnology
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
Biotechnology
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
Biotechnology
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
Biotechnology
2016
EMPLOYMENTAGREEMENT
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016